tryptophan hydroxylase 1 inhibitors (Nanjing University)

N/A

Report date: 2025/03/20 09:45:40
NME

Base Information

Drug Nametryptophan hydroxylase 1 inhibitors (Nanjing University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTryptophan hydroxylase 1 inhibitors
TargetsTryptophan hydroxylase 1
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing University
China Registration ClassN/A

Develop Information

Active CompaniesNanjing University
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A